# A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

> **NCT00466193** · PHASE3 · COMPLETED · sponsor: **Transcept Pharmaceuticals** · enrollment: 295 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** zolpidem tartrate sublingual tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00466193
- **Lead sponsor:** Transcept Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466193, "A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00466193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*